Eric J. Topol
Scripps Research Institute · 1,966 works · 187,830 citations · h-index 205
Top works
- High-performance medicine: the convergence of human and artificial intelligence
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
- Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
- Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia
- A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease
- Prevalence of Asymptomatic SARS-CoV-2 Infection
- Textbook of interventional cardiology
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
- Our Preoccupation With Coronary Luminology
- Assessing the impact of population stratification on genetic association studies
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
- Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation
- Myonecrosis After Revascularization Procedures
- Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries
- Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization